Together with the fact that the adeno-associated virus strategy was successfully used to treat retinal degeneration in human [46]–[48], it is conceivable that use of the NDI1 gene may prove to be a successful gene therapy to treat visual loss linked to mitochondrial optic neuropathy. This evidence concerns the gene AVPR2 and retinal degeneration.